Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06794840Not ApplicableNot Yet Recruiting

JomCare Study - A Harm Reduction Study

Role: collaborator

NCT07074171Not ApplicableCompleted

Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing

Role: collaborator

NCT05686837Enrolling By Invitation

Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria

Role: collaborator

NCT04787809Not ApplicableCompleted

Living Well: A Digital ACT Intervention

Role: lead

NCT05227339Phase 2Completed

RAE (Realize, Analyze, Engage)

Role: collaborator

NCT05816564Not ApplicableActive Not Recruiting

Optimizing Attentional Bias Modification

Role: lead

NCT03412097Completed

(MIST1)-Part 1: Assessment & Feasibility of Post-Symptoms Evaluation

Role: collaborator

All 7 trials loaded